All lobbying filings

Relx Inc.

Relx Inc. filed a Q3 report for Relx Inc. on October 16, 2025.

Lobbying for Relx Inc.

As filed: RELX INC. for RELX INC.

All filings by Relx Inc. · Everything Relx Inc. has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 16, 2025

Expenses

$720,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 8

Consumer Issues/Safety/Products

Issues related to support for consumer protection, fraud prevention and privacy. Issues related to comprehensive national privacy legislation.

Government Issues

Issues related to law enforcement investigative tools. Efforts to combat fraud and theft of pandemic relief benefits. Efforts to reduce unemployment insurance benefits fraud. Efforts to combat fraud and theft in small business loans. Efforts to prevent fraud in federal benefits. Fourth Amendment is Not For Sale Act, all provisions.

Issues related to copyright, including support for strong US intellectual property laws.

Medicare/Medicaid

Promoted program integrity related to: Sec. 1940 of the Social Security Act, all provisions; Sec. 1902(e) of the Social Security Act, all provisions related to income determined using modified adjusted gross income; and S 1082, Safeguarding Medicaid Act, all provisions.

Health Issues

Issues relating to consumer directed health information exchange, interoperability, information blocking, and patient access to health information. Issues relating to the impact of potential privacy legislation on Health Insurance Portability and Accountability Act (PL 104-191) and medical research. PL 116-260 Division BB Title I, No Surprises Act, provisions related to provider exchange network accuracy. Issues related to the education and awareness of the benefits of using real world data in healthcare research and development. Raising awareness of the use of artificial intelligence in healthcare, health education and research and development. Issues related to promoting research integrity.

Budget/Appropriations

Commerce, Justice, Science & Related Agencies Appropriations, provisions related to private sector information sales to government. PL 119-21, One Big Beautiful Bill Act, implementation of Title IV Subtitle D, Health; Title XI Subtitle C Part 3, Preventing Fraud, Waste and Abuse.

Taxation/Internal Revenue Code

Issues related to global tax policies, cross-national policies, and state and local policies.

Trade (domestic/foreign)

Issues related to global trade policy.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.